Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection (NCT03927027)
ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence After Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection With and Without Axillary Reverse Mapping
🩺 Plain-English Summary (8th-Grade Level)
This phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection. Axillary reverse mapping may help to preserve the lymph node drainage system around the breast so as to prevent lymphedema after surgery.
Who can join: Review the eligibility criteria below.
Location: University of Arkansas for Medical Sciences — Little Rock, Arkansas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (96 Sites)
Showing the first 25 of 96 sites.
- University of Arkansas for Medical Sciences — Little Rock, Arkansas
- UC San Diego Moores Cancer Center — La Jolla, California
- Contra Costa Regional Medical Center — Martinez, California
- Alta Bates Summit Medical Center - Summit Campus — Oakland, California
- Saint John's Cancer Institute — Santa Monica, California
- Shaw Cancer Center — Edwards, Colorado
- Beebe South Coastal Health Campus — Frankford, Delaware
- Helen F Graham Cancer Center — Newark, Delaware
- Christiana Care Health System-Christiana Hospital — Newark, Delaware
- Beebe Health Campus — Rehoboth Beach, Delaware
- UM Sylvester Comprehensive Cancer Center at Coral Gables — Coral Gables, Florida
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach — Deerfield Beach, Florida
- Holy Cross Hospital — Fort Lauderdale, Florida
- University of Florida Health Science Center - Gainesville — Gainesville, Florida
- Baptist MD Anderson Cancer Center — Jacksonville, Florida
- Mayo Clinic in Florida — Jacksonville, Florida
- University of Miami Miller School of Medicine-Sylvester Cancer Center — Miami, Florida
- UM Sylvester Comprehensive Cancer Center at Kendall — Miami, Florida
- Orlando Health Cancer Institute — Orlando, Florida
- UM Sylvester Comprehensive Cancer Center at Plantation — Plantation, Florida
- Piedmont Fayette Hospital — Fayetteville, Georgia
- Rush University Medical Center — Chicago, Illinois
- Advocate Christ Medical Center — Oak Lawn, Illinois
- Goshen Center for Cancer Care — Goshen, Indiana
- University of Kansas Cancer Center — Kansas City, Kansas
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Cancer Stage I
- A Study of the TheraBionic P1 Device in Breast Cancer — Clarkston, Michigan
- Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT) — Washington D.C., District of Columbia
Explore by condition: All Breast Cancer Stage I clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.